---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-032604"
form_type: "8-K"
ticker: "SMTI"
cik: "0000714256"
company_name: "Sanara MedTech Inc."
filed_at: "2021-12-28T23:59:59+00:00"
generated_at: "2026-06-27T22:13:53.398974+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Sanara MedTech appoints Zachary B. Fleming as CEO effective January 1, 2022

## Summary
- Zachary B. Fleming appointed CEO effective Jan 1, 2022; previously Co-COO & President of Surgical Division.
- Base salary raised from $225,000 to $290,000; eligible for annual restricted stock award up to 75% of salary.
- Eligible for annual cash bonus up to 50% of base salary; also receives customary benefits.
- Fleming led surgical division through double-digit revenue growth and COVID-19 challenges.
- Executive Chairman Ron Nixon expressed confidence in Fleming's leadership and strategic vision.

## SEC filing metadata
- accession: 0001493152-21-032604
- form_type: 8-K
- ticker: SMTI
- cik: 0000714256
- company_name: Sanara MedTech Inc.
- filed_at: 2021-12-28T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/714256/000149315221032604/0001493152-21-032604-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/714256/000149315221032604/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-032604
- JSON: https://secwatch.observer/filing/0001493152-21-032604.json
- Plain text: https://secwatch.observer/filing/0001493152-21-032604.txt

## Key facts
- Executive change
  Zachary B. Fleming was appointed as Chief Executive Officer at Sanara MedTech Inc..
  - Action: appointed
  - Role: Chief Executive Officer
  source text: On December 22, 2021, the Board of Directors (the “Board”) of Sanara MedTech Inc. (the “Company”) appointed Mr. Zachary B. Fleming as the Chief Executive Officer of the Company, effective January 1, 2021 (the “Effective Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/714256/000149315221032604/0001493152-21-032604-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.